• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

约旦心力衰竭患者的死亡风险因素:约旦心力衰竭登记处(JoHFR)。

Risk factors of mortality among heart failure patients in Jordan: the Jordanian Heart Failure Registry (JoHFR).

作者信息

Al-Balbissi Kais, Al-Saleh Akram, Al-Makhamreh Hanna, Abu-Hantash Hadi, Toubasi Ahmad, Albustanji Farah, Obaid Yazan Y, Abu Tawileh Hind, Al-Qalalweh Sarah, Mahmoud Mohammad Y, Hobeika Louis, Awaisheh Toqa, Izraiq Mahmoud

机构信息

Cardiology Section, Internal Medicine Department, Jordan University Hospital, Amman, Jordan.

Department of Cardiology, Amman Surgical Hospital, Amman, Jordan.

出版信息

Ann Med Surg (Lond). 2025 Apr 4;87(5):2659-2667. doi: 10.1097/MS9.0000000000003255. eCollection 2025 May.

DOI:10.1097/MS9.0000000000003255
PMID:40337431
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12055056/
Abstract

BACKGROUND

Heart failure is one of the most common medical burdens facing the healthcare system worldwide. Based on our knowledge, only two heart failure registries have been conducted in the Middle East. Therefore, we decided to conduct this heart failure registry to investigate the follow-up results of patients with both acute and chronic heart failure in Jordan.

METHODS

This study is a prospective observational multicenter national registry encompassing 21 health institutes in Jordan, comprising university hospitals, private hospitals, and private clinics. The criteria of inclusion were patients visiting the cardiology clinic or inpatients who were admitted due to acute decompensated HF. The primary outcome was 30-day mortality.

RESULTS

The total number of enrolled patients in the study was 2128, with a total number of deaths during the follow-up of 204. Multivariate analysis demonstrated that smoking (odds ratio [OR] = 3.214; 1.005-5139), positive family history of premature coronary artery disease (OR = 2.686; 1.504-4.798), insulin (OR = 2.300; 1.356-3.899), hyponatremia at presentation (OR = 7.058; 1.698-29.342) and increased left ventricular diameter (OR = 1.009; 1.002-1.016) were significantly associated with higher odds of mortality.

CONCLUSION

Smoking, positive family history of premature coronary artery disease, insulin use, hyponatremia on presentation, and increased left ventricular diameter were associated with patients' mortality. Physicians should monitor these factors among patients to identify patients who are at higher risk of detrimental outcomes.

摘要

背景

心力衰竭是全球医疗系统面临的最常见医疗负担之一。据我们所知,中东地区仅开展过两项心力衰竭登记研究。因此,我们决定开展这项心力衰竭登记研究,以调查约旦急性和慢性心力衰竭患者的随访结果。

方法

本研究是一项前瞻性观察性多中心全国登记研究,涵盖约旦的21家医疗机构,包括大学医院、私立医院和私人诊所。纳入标准为就诊于心脏病诊所的患者或因急性失代偿性心力衰竭入院的住院患者。主要结局为30天死亡率。

结果

该研究共纳入2128例患者,随访期间共有204例死亡。多因素分析表明,吸烟(比值比[OR]=3.214;1.005 - 5.139)、早发冠状动脉疾病家族史阳性(OR = 2.686;1.504 - 4.798)、胰岛素使用(OR = 2.300;1.356 - 3.899)、就诊时低钠血症(OR = 7.058;1.698 - 29.342)和左心室直径增大(OR = 1.009;1.002 - 1.016)与较高的死亡几率显著相关。

结论

吸烟、早发冠状动脉疾病家族史阳性、胰岛素使用、就诊时低钠血症和左心室直径增大与患者死亡率相关。医生应在患者中监测这些因素,以识别出不良结局风险较高的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8329/12055056/55e6432bd223/ms9-87-2659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8329/12055056/a3b71ed4f60a/ms9-87-2659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8329/12055056/2d9cfdb11aa2/ms9-87-2659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8329/12055056/55e6432bd223/ms9-87-2659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8329/12055056/a3b71ed4f60a/ms9-87-2659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8329/12055056/2d9cfdb11aa2/ms9-87-2659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8329/12055056/55e6432bd223/ms9-87-2659-g003.jpg

相似文献

1
Risk factors of mortality among heart failure patients in Jordan: the Jordanian Heart Failure Registry (JoHFR).约旦心力衰竭患者的死亡风险因素:约旦心力衰竭登记处(JoHFR)。
Ann Med Surg (Lond). 2025 Apr 4;87(5):2659-2667. doi: 10.1097/MS9.0000000000003255. eCollection 2025 May.
2
Machine Learning-Based Mortality Prediction in Chronic Kidney Disease among Heart Failure Patients: Insights and Outcomes from the Jordanian Heart Failure Registry.基于机器学习的心力衰竭合并慢性肾脏病患者死亡率预测:来自约旦心力衰竭注册研究的结果和启示
Medicina (Kaunas). 2024 May 19;60(5):831. doi: 10.3390/medicina60050831.
3
The use of four-pillar regimen for heart failure management: results from the Jordanian Heart Failure Registry (JoHFR).四步治疗方案在心力衰竭管理中的应用:来自约旦心力衰竭注册研究(JoHFR)的结果。
PeerJ. 2024 Nov 19;12:e18464. doi: 10.7717/peerj.18464. eCollection 2024.
4
Comparing acute and chronic heart failure patients: the Jordanian Heart Failure Registry (JoHFR).比较急性和慢性心力衰竭患者:约旦心力衰竭登记处(JoHFR)。
Minerva Cardiol Angiol. 2025 Aug;73(4):515-522. doi: 10.23736/S2724-5683.24.06659-6. Epub 2025 Mar 28.
5
Clinical profile and 90 day outcomes of 10 851 heart failure patients across India: National Heart Failure Registry.印度 10851 例心力衰竭患者的临床特征和 90 天结局:国家心力衰竭注册研究。
ESC Heart Fail. 2022 Dec;9(6):3898-3908. doi: 10.1002/ehf2.14096. Epub 2022 Aug 10.
6
Taiwan Society of Cardiology Heart Failure Registry 2020: Rationale and Design.2020年台湾心脏病学会心力衰竭注册研究:原理与设计
Acta Cardiol Sin. 2024 Mar;40(2):235-241. doi: 10.6515/ACS.202403_40(2).20230822A.
7
Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR).急性失代偿性心力衰竭患者的临床特征和 30 天结局:来自印度心脏病学会国家心力衰竭登记处(ICCNHFR)的结果。
Int J Cardiol. 2022 Jun 1;356:73-78. doi: 10.1016/j.ijcard.2022.03.021. Epub 2022 Mar 13.
8
Impact of Diabetes Mellitus on Heart Failure Patients: Insights from a Comprehensive Analysis and Machine Learning Model Using the Jordanian Heart Failure Registry.糖尿病对心力衰竭患者的影响:基于约旦心力衰竭登记处的综合分析和机器学习模型的见解
Int J Gen Med. 2024 May 18;17:2253-2264. doi: 10.2147/IJGM.S465169. eCollection 2024.
9
Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1).中东患者经皮冠状动脉介入治疗后支架血栓形成的发生率及预后:首个约旦经皮冠状动脉介入治疗注册研究(JoPCR1)
Ann Saudi Med. 2016 Jan-Feb;36(1):17-22. doi: 10.5144/0256-4947.2016.17.
10
Comparison of Characteristics and Outcomes in Patients With Acute Decompensated Heart Failure Admitted Under General Medicine and Cardiology Units.比较综合医学科和心内科收治的急性失代偿性心力衰竭患者的特征和结局。
Heart Lung Circ. 2024 Jul;33(7):983-989. doi: 10.1016/j.hlc.2024.01.016. Epub 2024 Mar 7.

本文引用的文献

1
Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives.他汀类药物在射血分数保留型心力衰竭中的应用:当前的证据和观点。
Int J Mol Sci. 2024 May 1;25(9):4958. doi: 10.3390/ijms25094958.
2
Lipoprotein(a), family history of cardiovascular disease, and incidence of heart failure.脂蛋白(a)、心血管疾病家族史与心力衰竭发病率
J Lipid Res. 2023 Jul;64(7):100398. doi: 10.1016/j.jlr.2023.100398. Epub 2023 Jun 3.
3
Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis.
射血分数保留和轻度降低的心衰的最佳药物治疗:一项荟萃分析。
JAMA Netw Open. 2022 Sep 1;5(9):e2231963. doi: 10.1001/jamanetworkopen.2022.31963.
4
Counteracting heart failure with diabetes drugs: a review into the pharmacokinetic and pharmacodynamic properties.用糖尿病药物治疗心力衰竭:对药代动力学和药效学特性的综述。
Expert Opin Drug Metab Toxicol. 2022 Jun;18(6):381-393. doi: 10.1080/17425255.2022.2105693. Epub 2022 Aug 2.
5
HDL Composition, Heart Failure, and Its Comorbidities.高密度脂蛋白成分、心力衰竭及其合并症
Front Cardiovasc Med. 2022 Mar 8;9:846990. doi: 10.3389/fcvm.2022.846990. eCollection 2022.
6
Global burden of heart failure: a comprehensive and updated review of epidemiology.心力衰竭的全球负担:流行病学的全面更新综述
Cardiovasc Res. 2023 Jan 18;118(17):3272-3287. doi: 10.1093/cvr/cvac013.
7
A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭的药物治疗的系统评价和网络荟萃分析。
JACC Heart Fail. 2022 Feb;10(2):73-84. doi: 10.1016/j.jchf.2021.09.004. Epub 2021 Dec 8.
8
STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery.STROCSS 2021:加强外科学队列研究、横断面研究和病例对照研究报告规范。
Int J Surg. 2021 Dec;96:106165. doi: 10.1016/j.ijsu.2021.106165. Epub 2021 Nov 11.
9
Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure.高血压、肥胖、左心室肥厚和心力衰竭的相互作用。
Curr Opin Cardiol. 2021 Jul 1;36(4):453-460. doi: 10.1097/HCO.0000000000000868.
10
Lipoprotein(a) and Coronary Artery Disease Risk Without a Family History of Heart Disease.无心脏病家族史情况下的脂蛋白(a)与冠状动脉疾病风险
J Am Heart Assoc. 2021 Feb;10(5):e017470. doi: 10.1161/JAHA.120.017470. Epub 2021 Feb 26.